HBI Deals+Insights / M&A/IPOs
ARCHIMED, a global investment firm focused on sustainable healthcare, has announced the sale of DIESSE, an Italian producer of specialty in-vitro diagnostics (IVD) solutions, to private equity firm Fremman Capital.





